| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $39.20K | $40.48K | $68.03K | $62.30K | $282.81K |
| R&D | – | – | – | – | – |
| SG&A | $39.20K | $40.48K | $68.03K | $62.30K | $282.81K |
| Operating Income | – | – | -$68.03K | -$62.30K | -$282.81K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$39.20K | -$40.48K | -$68.03K | $8.27M | -$282.81K |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0100 | 0.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0100 | – |
| Shares (diluted) | $603.97M | $603.97M | $603.97M | $603.97M | – |